August 20, 2014 1:58 AM ET

Pharmaceuticals

Company Overview of NovaCardia, Inc.

Company Overview

NovaCardia, Inc., a clinical-stage pharmaceutical company, focuses on developing drugs to treat cardiovascular diseases. The company is developing KW-3902, an adenosine A1 receptor antagonist, which is in Phase III clinical trials for the treatment of the acute form of congestive heart failure in patients with renal impairment and fluid overload. It is also developing an oral formulation of KW-3902 for the treatment of chronic congestive heart failure. In addition, the company is developing K201 (JTV-519) for the treatment of atrial fibrillation, an irregular heartbeat. The company was founded in 2001 and is headquartered in San Diego, California. As of September 11, 2007, NovaCardia, Inc. o...

12750 High Bluff Drive

Suite 300

San Diego, CA 92130

United States

Founded in 2001

11 Employees

Phone:

858-509-0455

Fax:

858-509-0456

Key Executives for NovaCardia, Inc.

Chief Financial Officer and Principal Accounting Officer
Age: 59
Secretary
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Primus Pharmaceuticals, Inc. United States
Elite Laboratories, Inc. United States
Abatic Pharmaceutical United States
Aerpio Therapeutics, Inc. United States
Vitalife, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NovaCardia, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.